Ledger.Open graph →
SEC Form D · filed November 30, 2022

Chimeron Bio Corp

Offering
$10.0M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Kevin Heyeck · Philadelphia, PAExec · DirectorAfshin Safavi · Philadelphia, PADirectorAntonin De Fougerolles · Philadelphia, PADirectorGorka Fius · Philadelphia, PADirectorThimmaiah Chendrimada · Philadelphia, PAExecCatalyst Impact Partners, Corp · Cambridge, MAExec · DirectorRyan Clinton · Memphis, TNDirectorEdward H. O'Donnell · Houston, TXDirectorGorka Fius · Philadelphia, PADirectorJames N. Falbe · Chandler, AZExec · DirectorDennis Bethel · FRIANT, CADirectorChris Justin · NEW ORLEANS, LADirectorThimmaiah Chendrimada · Philadelphia, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗